Germany says COVID-19 vaccine unlikely before mid-2021

Karliczek said Germany was providing funding grants to three German biotech firms — CureVac from Tübingen, BioNTech from Mainz and Dessau-based IDT Biologika so they could speed up the development of coronavirus vaccine candidates.about:blank

“All three of them are promising candidates but we must of course always expect setbacks during the testing phase because it’s one thing to have an effective vaccine but it’s another to have a safe vaccine that people want,” the minister said.

Europe’s largest economy has reported a rise in infections in recent days, with the head of Germany’s Robert Koch Institute (RKI) for infectious diseases blaming negligence and saying it was unclear if a second wave was underway.

More than 150 vaccine candidates are in various stages of development, with 23 prospects in human trials across the globe.

Published by Shivam Choudhary

BEST INFORMATION AVAILABLE

2 thoughts on “Germany says COVID-19 vaccine unlikely before mid-2021

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

Create your website with WordPress.com
Get started
%d bloggers like this: